The Betterhumans Team
Learn about Betterhumans Inc. a 501(c)(3), tax-exempt scientific research organization.
Meet the Betterhuman team, sponsor of the world's most comprehensive genomic research study of supercentenarians and their families.
Research Fellow in Psychiatry at the Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia. In 2011, he was the first to show that NAD+ levels decline with ageing, and enzymes involved in NAD+ synthesis are dysregulated during the pace of ageing. He has published over 82 peer reviewed publications (H index = 20), 6 book chapters, 2 books and 1 international patent on a pharmacological formulation to promote NAD+ synthesis in mammalian cells.
Prof of Genetics, Harvard Medical School, Dir of the Center for Computational Genetics. 1984 Harvard PhD included the first direct genomic sequencing method, molecular multiplexing tags, which lead to automation & software used at Genome Therapeutics Corp. for the first commercial genome sequence -- pathogen, Helicobacter in 1994.
Attorney turned entrepreneur, turned scientist.
PhD Candidate at Harvard University and the Wyss Institute for Biologically Inspired Engineering. Former bioinformatics analyst at the Stower's Institute for Medical Research conducting analyses of next generation sequencing data and regulatory genomics.
Research Fellow in Genetics under George Church at Harvard Medical School. Developed high-throughput approaches for studying ageing, including computational tools and databases. Currently, lecturer in Biological Sciences at University of Liverpool.
Chief Science Officer at Genomera, Chair of the Biotechnology Track, Singularity University, former Sr. Bioinformatics Scientist at Illumina; next generation sequencing technology to develop new applications in gene expression, including miRNA, ChIP-Seq, methylation and epigenomics.